main-logo

ICD-10 Code C90.21 | Extramedullary plasmacytoma in remission Symptoms, Diagnosis, Billing

Extramedullary plasmacytoma in remission is a localized tumor of plasma cells occurring outside the bone marrow, often associated with multiple myeloma. Accurate coding with ICD-10 Code C90.21 is essential for proper diagnosis, documentation, and billing, ensuring appropriate treatment and resource allocation in healthcare settings.

What is ICD-10 Code C90.21 for Extramedullary plasmacytoma in remission?

ICD-10 Code C90.21 represents Extramedullary plasmacytoma in remission, indicating a state where the tumor has responded to treatment and is no longer active. This code is used in clinical documentation and billing to signify the patient's current health status and to track treatment outcomes related to plasma cell disorders.

ICD-10 Code C90.21 – Clinical Definition and Explanation of Extramedullary plasmacytoma in remission

Extramedullary plasmacytoma in remission is characterized by the presence of plasma cell tumors outside the bone marrow, typically in soft tissues. These tumors can arise from underlying multiple myeloma or occur independently. Medical attention is crucial to monitor for potential recurrence or complications.

Key Clinical Features:

  • Localized tumor formation in soft tissues, often in the head, neck, or gastrointestinal tract.
  • Symptoms may include swelling, pain, or mass effect depending on the tumor location.
  • Diagnosis is confirmed through imaging studies and biopsy.
  • Regular follow-up is necessary to monitor for recurrence.

ICD-10 Code C90.21 for Extramedullary plasmacytoma in remission – SOAP Notes & Clinical Use

ICD-10 Code C90.21 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code C90.21 for Extramedullary plasmacytoma in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C90.21 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C90.21 – Extramedullary plasmacytoma in remission

Management of Extramedullary plasmacytoma in remission focuses on monitoring and supportive care to prevent recurrence.

Antibiotic Therapy:

  • Not applicable as the condition is not infectious.

Supportive Care:

  • Regular follow-up imaging to monitor for recurrence.
  • Pain management as needed.
  • Patient education on signs of recurrence.

Infection Control:

  • Standard precautions to prevent infections during treatment.

How to Document Symptoms of Extramedullary plasmacytoma in remission (ICD-10 C90.21) in SOAP Notes

Subjective:

  • Patient reports no current symptoms related to the extramedullary plasmacytoma.
  • History of localized swelling in the previous tumor site.
  • Denies any new masses or pain.
  • Patient expresses concern about potential recurrence.

Objective:

  • Physical examination reveals no palpable masses.
  • Imaging studies show no evidence of active disease.
  • Vital signs within normal limits.
  • Laboratory tests indicate stable serum protein levels.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Extramedullary plasmacytoma in remission (ICD-10 Code C90.21)

Assessment:

  • Diagnosis: Extramedullary plasmacytoma in remission.
  • Severity: Currently asymptomatic with no evidence of disease.
  • Relevant ICD-10 subcode: C90.21.
  • Contributing factors: Previous treatment for multiple myeloma.

Plan:

  • Continue regular follow-up appointments every 3-6 months.
  • Educate the patient on signs of recurrence and when to seek care.
  • Monitor serum protein levels and perform imaging as indicated.
  • Schedule follow-up in 6 months.

Treatment & Plan Section for ICD-10 Code C90.21 – Extramedullary plasmacytoma in remission

  • Regular follow-up appointments to monitor for recurrence.
  • Patient education on symptoms of potential relapse.
  • Imaging studies as needed based on clinical findings.
  • Supportive care for any residual symptoms.

Using ICD-10 Code C90.21 for Extramedullary plasmacytoma in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of the patient's remission status in the Subjective and Objective sections.
  • Use C90.21 in billing to reflect the patient's current health status.
  • Include relevant clinical findings to support the diagnosis.
  • Align treatment plans with clinical guidelines to justify billing.

ICD-10 Code C90.21 in Medical Billing and Insurance for Extramedullary plasmacytoma in remission

ICD-10 Code C90.21 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

  • Document the patient's remission status clearly in the medical record.
  • Use C90.21 in appropriate clinical settings to support claims.
  • Include relevant clinical findings and treatment plans in documentation.
  • Ensure compliance with coding guidelines to avoid claim denials.

Common CPT Pairings:

CPT CodeDescription
99213Established patient office visit, low complexity.
36415Collection of venous blood by venipuncture.
85025Complete blood count with automated differential.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C90.21 for Extramedullary plasmacytoma in remission

What does it mean if a patient has Extramedullary plasmacytoma in remission?

It indicates that the plasma cell tumor has responded to treatment and is no longer active, but ongoing monitoring is essential to detect any potential recurrence.

How is Extramedullary plasmacytoma diagnosed?

Diagnosis typically involves imaging studies and biopsy to confirm the presence of plasma cell tumors outside the bone marrow.

What are the treatment options for Extramedullary plasmacytoma?

Treatment may include radiation therapy, chemotherapy, and regular monitoring for recurrence, depending on the patient's overall health and previous treatments.

How often should follow-up appointments occur for patients in remission?

Patients in remission should have follow-up appointments every 3-6 months to monitor for any signs of recurrence or complications.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved